Strata Skin Sciences announces JCAD publication highlighting TheraClearX for acne treatment

STRATA Skin Sciences, Inc.

Journal of Clinical and Aesthetic Dermatology published review and expert article on TheraClearX for mild-to-moderate acne vulgaris.
Article highlights visible improvement as early as second treatment, no downtime, and customization for all Fitzpatrick skin types.
CEO Bob Moccia stated the publication expands on device's safety, efficacy, and integration into practice.
Dr. Gilly Munavalli, author, noted TheraClearX is effective non-pharmaceutical acne treatment with little downtime.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.